Is TYRA or UTHR more undervalued in 2026?

CirclFi compares Tyra Biosciences, Inc. (TYRA) and United Therapeutics Corporation (UTHR) using 13 institutional-grade valuation models. TYRA has a Quality of Company score of 4.3/10 while UTHR scores 10.0/10.

Which is a better buy — TYRA or UTHR?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do TYRA and UTHR valuations compare?

TYRA at $33.41 and UTHR at $556.82 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

TYRA vs UTHR Valuation Comparison 2026 — Intrinsic Value Analysis

TYRA

Pharmaceutical Preparations

Tyra Biosciences, Inc.

Quality

4.3

out of 10

Value Trap

SAFE

Price

$33.41

Last close

Models

7/13

Active

UTHR

Pharmaceutical Preparations

United Therapeutics Corporation

Quality

10.0

out of 10

Value Trap

—

Price

$556.82

Last close

Models

13/13

Active

Model-by-Model Comparison

Model	Type	TYRA Fair Value	TYRA Upside	UTHR Fair Value	UTHR Upside
Bayesian DCF	Intrinsic	$9.65	-71.1%	$307.56	-44.8%
Earnings Power Value	Intrinsic	—	—	$248.41	-55.4%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$5.32	-84.1%	$76.75	-86.2%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for TYRA vs UTHR — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

TYRA vs UTHR — Which Stock Is More Undervalued?

UTHR scores higher with a 10.0/10 quality rating vs TYRA's 4.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Tyra Biosciences, Inc. (TYRA) and United Therapeutics Corporation (UTHR) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

TYRA currently trades at $33.41 with a QOC of 4.3/10, while UTHR trades at $556.82 with a QOC of 10.0/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).